Cytokinetics
Clinical trials sponsored by Cytokinetics, explained in plain language.
-
New hope for kids with thickened hearts
Disease control Recruiting nowThis study is testing whether a drug called aficamten is safe and effective for children and teenagers with a genetic condition that causes the heart muscle to thicken, making it harder to pump blood. Participants will take the drug or a placebo for 12 weeks, followed by a longer…
Phase: PHASE2, PHASE3 • Sponsor: Cytokinetics • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New heart failure drug enters Mid-Stage testing
Disease control Recruiting nowThis study is testing an investigational drug called CK-4021586 in adults with a specific type of heart failure where the heart pumps normally but still causes symptoms like shortness of fatigue. The main goals are to find a safe and effective dose and see how the body processes …
Phase: PHASE2 • Sponsor: Cytokinetics • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Major trial tests drug to keep severe heart failure patients out of hospital
Disease control Recruiting nowThis large, late-stage trial is testing whether a new drug called omecamtiv mecarbil can help people with severe heart failure. It aims to see if the drug reduces the risk of serious events like hospitalization, needing a heart device or transplant, or death. About 1,800 particip…
Phase: PHASE3 • Sponsor: Cytokinetics • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC